Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/9378
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDinh, Diem Ten
dc.contributor.authorFrauman, Albert Gen
dc.contributor.authorSomers, Gino Ren
dc.contributor.authorOhishi, Mitsuruen
dc.contributor.authorZhou, Jialongen
dc.contributor.authorCasley, David Jen
dc.contributor.authorJohnston, Colin Ien
dc.contributor.authorFabiani, Maurice Een
dc.date.accessioned2015-05-15T22:27:10Z
dc.date.available2015-05-15T22:27:10Z
dc.date.issued2002-02-01en
dc.identifier.citationThe Journal of Pathology; 196(2): 213-9en
dc.identifier.govdoc11793373en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/9378en
dc.description.abstractThe expression and cellular localization of angiotensin II (Ang II) and AT(1) receptor proteins were examined in the normal human prostate and benign prostatic hyperplasia (BPH) by immunohistochemistry. In the normal prostate, Ang II immunoreactivity was localized to the basal layer of the epithelium and AT(1) receptor immunostaining was found predominantly on stromal smooth muscle and also on vascular smooth muscle of prostatic blood vessels. Ang II immunoreactivity was markedly increased in hyperplastic acini in BPH compared with acini in the normal prostate (normal: 7.4+/-0.2%, n=5 vs. BPH: 22.7+/-1.9%, n=5, p<0.001). However, AT(1) receptor immunoreactivity was significantly decreased in BPH compared with the normal prostate [normal: 16.4+/-2.2%, n=4 vs. BPH: 9.4+/-1.3%, n=5, p<0.05 (p=0.025)]. The present study demonstrates the presence of Ang II peptide in the basal layer of the epithelium and AT(1) receptors on stromal smooth muscle, suggesting that Ang II may mediate paracrine functions on cellular growth and smooth muscle tone in the human prostate. Furthermore, AT(1) receptor down-regulation in BPH may be due to receptor hyperstimulation by increased local levels of Ang II in BPH. These data extend previous findings in support of the novel concept that overactivity of the renin-angiotensin system (RAS) may be involved in the pathophysiology of BPH.en
dc.language.isoenen
dc.subject.otherAngiotensin I.metabolismen
dc.subject.otherAngiotensin II.analysisen
dc.subject.otherCase-Control Studiesen
dc.subject.otherEpithelium.chemistryen
dc.subject.otherHumansen
dc.subject.otherImmunohistochemistry.methodsen
dc.subject.otherMaleen
dc.subject.otherMuscle, Smooth, Vascular.chemistryen
dc.subject.otherProstate.blood supply.chemistryen
dc.subject.otherProstatic Hyperplasia.metabolismen
dc.subject.otherReceptors, Angiotensin.analysisen
dc.subject.otherRenin-Angiotensin System.physiologyen
dc.titleEvidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Journal of pathologyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin & Repatriation Medical Centre, Heidelberg, VIC 3084, Australiaen
dc.identifier.doi10.1002/path.1021en
dc.description.pages213-9en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/11793373en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.